Ca2+ < Cabergoline < Cadaver

Facettes :

List of bibliographic references indexed by Cabergoline

Number of relevant bibliographic references: 11.

Ident.	Authors (with country if any)	Title
001E39 (2010)	Pershia Samadi [Canada] ; Marc Morissette [Canada] ; Daniel Lévesque [Canada] ; Thérèse Di Paolo [Canada]	BDNF levels are not related with levodopa‐induced dyskinesias in MPTP monkeys
002D48 (2007)	Gregor Simonis [Allemagne] ; Joerg T. Fuhrmann [Allemagne] ; Ruth H. Strasser [Allemagne]	Meta‐analysis of heart valve abnormalities in Parkinson's disease patients treated with dopamine agonists
002E65 (2007)	Günther Deuschl [Allemagne] ; Antanas Vaitkus [Lituanie] ; Gabriele-Cornelia Fox ; Torsten Roscher ; Dieter Schremmer [Allemagne] ; Ariel Gordin	Efficacy and tolerability of entacapone versus cabergoline in parkinsonian patients suffering from wearing‐off
002F76 (2007)	Claudia Trenkwalder [Allemagne] ; Heike Benes [Allemagne] ; Ludger Grote [Suède] ; Svenja Happe [Allemagne] ; Birgit Högl [Autriche] ; Johannes Mathis [Suisse] ; Gerda M. Saletu-Zyhlarz [Autriche] ; Ralf Kohnen [Allemagne]	Cabergoline compared to levodopa in the treatment of patients with severe restless legs syndrome: Results from a multi‐center, randomized, active controlled trial
004155 (2003)	Nancy Bélanger [Canada] ; Laurent Grégoire [Canada] ; Abdallah Hadj Tahar [Canada] ; Paul J. Bédard [Canada]	Chronic treatment with small doses of cabergoline prevents dopa‐induced dyskinesias in parkinsonian monkeys
004165 (2003)	Antje M. Smala [Allemagne] ; E. Annika Spottke [Allemagne] ; Olaf Machat [Allemagne] ; Uwe Siebert [États-Unis] ; Dieter Meyer [Allemagne] ; Rudolf Köhne-Volland [Allemagne] ; Martin Reuther [Allemagne] ; Janeen Duchane [États-Unis] ; Wolfgang H. Oertel [Allemagne] ; Karin B. Berger [Allemagne] ; Richard C. Dodel [Allemagne]	Cabergoline versus levodopa monotherapy: A decision analysis
004550 (2002)	Jakob Christensen [Danemark] ; Erik Dupont [Danemark] ; Karen Stergaard [Danemark]	Cabergoline plasma concentration is increased during concomitant treatment with itraconazole
004634 (2002)		DA agonists: Ergot derivatives: Cabergoline
004C17 (1999)	Jean Louis Montastruc [France] ; Olivier Rascol [France] ; Jean-Michel Senard [France]	Treatment of Parkinson's disease should begin with a dopamine agonist
005686 (1996)	Geminiani [Italie] ; Vincenza Fetoni [Italie] ; Silvia Genitrini [Italie] ; Paolo Giovannini [Italie] ; Filippo Tamma [Italie] ; Tommaso Caraceni [Italie]	Cabergoline in Parkinson's disease complicated by motor fluctuations
005875 (1995)	R. Inzelberg [Israël] ; P. Nisipeanu [Israël] ; M. J. Rabey [Israël] ; Korczyn [Israël]	Long‐term tolerability and efficacy of cabergoline, a new long‐acting dopamine agonist, in Parkinson's disease

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Cabergoline" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Cabergoline" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Cabergoline
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024